Effect of ramucirumab on ALBI grade in patients with advanced HCC: Results from REACH and REACH-2

BACKGROUND & AIMS: The albumin–bilirubin (ALBI) grade/score is derived from a validated nomogram to objectively assess prognosis and liver function in patients with hepatocellular carcinoma (HCC). In this post hoc analysis, we assessed prognosis in terms of survival by baseline ALBI grade and mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Kudo, Masatoshi, Galle, Peter R., Brandi, Giovanni, Kang, Yoon-Koo, Yen, Chia-Jui, Finn, Richard S., Llovet, Josep M., Assenat, Eric, Merle, Philippe, Chan, Stephen L., Palmer, Daniel H., Ikeda, Masafumi, Yamashita, Tatsuya, Vogel, Arndt, Huang, Yi-Hsiang, Abada, Paolo B., Yoshikawa, Reigetsu, Shinozaki, Kenta, Wang, Chunxiao, Widau, Ryan C., Zhu, Andrew X.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772786/
https://www.ncbi.nlm.nih.gov/pubmed/33392490
http://dx.doi.org/10.1016/j.jhepr.2020.100215

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772786/
https://www.ncbi.nlm.nih.gov/pubmed/33392490
http://dx.doi.org/10.1016/j.jhepr.2020.100215

Ejemplares similares